title: Experience with a measles vaccine manufactured in India.
abstract: Five hundred and twenty seven children between 7 months and 2 years of age were vaccinated with measles vaccine manufactured by the Serum Institute of India. The sero-conversion rate in children who had no antibodies previous to vaccination was 98.4% as tested in HI. Ninety per cent of children who had pre-vaccination measles antibodies showed a two-fold or more rise in HI antibodies. The side reactions of the vaccine were negligible.
authors.affiliation: National Institute of Virology, Pune.
authors.forename: N
authors.initials: N
authors.lastname: Shaikh
authors.forename: S K
authors.initials: SK
authors.lastname: Raut
authors.forename: S S
authors.initials: SS
authors.lastname: Bedekar
authors.forename: M A
authors.initials: MA
authors.lastname: Phadke
authors.forename: K
authors.initials: K
authors.lastname: Banerjee
mesh_terms: D000914:Antibodies, Viral / Q000097:blood*; D002675:Child, Preschool; D006801:Humans; D007194:India; D007223:Infant; D008458:Measles Vaccine / Q000276:immunology*; D008459:Measles virus / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D008458:Measles Vaccine